Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00096876 · ClinicalTrials.gov registry record
A Study of the Sense of Smell in Relatives of Parkinson's Disease Patients
A clinical trial, sponsored by Institute for Neurodegenerative Disorders.
- Completed
- Registry status
- 600
- Enrollment target
NCT00096876: Completed study, sponsored by Institute for Neurodegenerative Disorders.
NCT00096876 is a clinical trial that has completed, run by Institute for Neurodegenerative Disorders. The registered enrollment target is 600 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00096876 has completed, sponsored by Institute for Neurodegenerative Disorders.
- COMPLETED
- Registry status
- 600 participants
- Enrollment target
Study Summary
In this study, individuals complete and return a mail survey, specifically a 40 item scratch and sniff smell test.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2004-10 |
| Est. Completion | 2008-06 |
What the finished NCT00096876 record still lists
NCT00096876 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00096876 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00096876 about?
NCT00096876 is a clinical study titled "A Study of the Sense of Smell in Relatives of Parkinson's Disease Patients". In this study, individuals complete and return a mail survey, specifically a 40 item scratch and sniff smell test.
What is the current status of trial NCT00096876?
This trial is currently completed. The enrollment target is 600 participants. The study started on 2004-10. Estimated completion is 2008-06.
Who is sponsoring clinical trial NCT00096876?
This trial is sponsored by Institute for Neurodegenerative Disorders, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia